New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
Monoclonal antibody cliramitug shows sustained benefit in cardiac amyloidosis over 29 months
Long-term follow-up of the NI006-101 trial shows that cliramitug, a monoclonal antibody targeting misfolded transthyretin, sustains clinical benefit in cardiac…
Editor's Top Picks
AI-Assisted Clinical Decision Support Shows No Benefit Over Standard Care in Kenyan Primary Care Study
A pragmatic cluster-randomized trial in Kenya found that ChatGPT-4o-assisted clinical decision support did not significantly reduce treatment failure rates in…
Submit Your Paper →
More form New Studies
Severe Infant Symptoms Paradoxically Reduce Healthcare Seeking in Sub-Saharan Africa
New research reveals severely ill neonates received formal healthcare in only 8.4%-41.8% of fatal cases,…
Vitamin D2 Supplements May Lower Body’s More Effective D3 Levels, Study Warns
New research reveals vitamin D2 supplements may reduce the body's levels of vitamin D3, the…
L-Arginine Shows Unexpected Brain Benefits Beyond Blood Vessel Function
L-arginine demonstrates unexpected neurological benefits beyond cardiovascular health, improving brain blood flow and potentially influencing…
Apigenin Sleep and Longevity Claims Face Scientific Scrutiny
Apigenin features in popular sleep supplements and longevity protocols despite limited human clinical evidence. Only…
New Study Reveals How Alcohol Disables Gut Immune Defenses, Worsening Liver Disease
New research published in Nature reveals how chronic alcohol consumption disables gut immune defenses, allowing…